Sun Pharma extends fall despite clarification on corporate governance issue

The stock is down 3% at Rs 442 on Tuesday, extending its 7.5% fall on Monday on the BSE.

The revenue from operations declined to ~69.7 bn for the fourth quarter against ~71.3 bn during the same period last year

Shares of Sun Pharmaceutical Industries moved down by 3% to Rs 442 per share, falling 5% from their early morning high of Rs 465 apiece on BSE, even though the company made a clarification related to corporate governance and whistleblower issues. The stock had ended 7.5% lower at Rs 455 yesterday. It was trading close to its 52-week low price of Rs 435 touched on May 22, 2018, in the intra-day trade. The trading volumes on the counter nearly doubled with a combined 31.59 million equity shares changed hands on the NSE and BSE so far. Sun Pharmaceutical Industries on Monday said ...